Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study

BACKGROUND: Direct-acting antivirals (DAAs) are recommended for the treatment of hepatitis C virus (HCV) infection in patients treated with methadone or buprenorphine. AIM: To assess HCV treatment rates in an Opioid Treatment Program (OTP). METHODS: This longitudinal study included 501 patients (81....

Descripción completa

Detalles Bibliográficos
Autores principales: Sanvisens, Arantza, Rivas, Inmaculada, Faure, Eva, Espinach, Néstor, Hernandez-Rubio, Anna, Majó, Xavier, Colom, Joan, Muga, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579757/
https://www.ncbi.nlm.nih.gov/pubmed/33132641
http://dx.doi.org/10.3748/wjg.v26.i38.5874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579757/
https://www.ncbi.nlm.nih.gov/pubmed/33132641
http://dx.doi.org/10.3748/wjg.v26.i38.5874

Ejemplares similares